Cargando…

The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients

AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustonen, Jyrki, Rautiainen, Päivi, Lamidi, Marja-Leena, Lavikainen, Piia, Martikainen, Janne, Laatikainen, Tiina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198841/
https://www.ncbi.nlm.nih.gov/pubmed/36977968
http://dx.doi.org/10.1007/s00592-023-02079-y
_version_ 1785044815500541952
author Mustonen, Jyrki
Rautiainen, Päivi
Lamidi, Marja-Leena
Lavikainen, Piia
Martikainen, Janne
Laatikainen, Tiina
author_facet Mustonen, Jyrki
Rautiainen, Päivi
Lamidi, Marja-Leena
Lavikainen, Piia
Martikainen, Janne
Laatikainen, Tiina
author_sort Mustonen, Jyrki
collection PubMed
description AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health records in Siun sote region in Eastern Finland. A retrospective real-world analysis was conducted combining hospital admission and prehospital emergency service data to compare incidences of hypoglycemia requiring emergency medical support (EMS) involvement or hospital admission and diabetic ketoacidosis (DKA) before and after the start of isCGM. Data were collected from January 2015 to April 2020. Primary outcome was the rate of hypoglycemia requiring EMS involvement or hospital admission and DKA events. HbA1c was recorded at the start of isCGM and was compared with the last known HbA1c during the use of isCGM. The isCGM used in the study did not contain alarm functions. RESULTS: Altogether 220 hypoglycemic events were identified during the study period. Incidence rate of hypoglycemic events decreased after the start of isCGM (72 events, incidence rate 50 events/1000 person-years) compared with the time before the start (148 events, incidence rate 76 events/1000 person-years) (p = 0.043). The incidence rate of DKA decreased after the start of isCGM compared with time before isCGM use (4 and 15 events/1000 person-years, respectively; p = 0.002). The change in mean HbA1c was − 0.28% (− 3.1 mmol/mol) between baseline and the last HbA1c measurement (p < 0.001). CONCLUSIONS: In addition to lowering HbA1c in type 1 diabetes patients, isCGM is also effective in preventing acute diabetes-related complications such as hypoglycemia requiring EMS involvement or hospital admission and DKA.
format Online
Article
Text
id pubmed-10198841
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-101988412023-05-21 The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients Mustonen, Jyrki Rautiainen, Päivi Lamidi, Marja-Leena Lavikainen, Piia Martikainen, Janne Laatikainen, Tiina Acta Diabetol Original Article AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health records in Siun sote region in Eastern Finland. A retrospective real-world analysis was conducted combining hospital admission and prehospital emergency service data to compare incidences of hypoglycemia requiring emergency medical support (EMS) involvement or hospital admission and diabetic ketoacidosis (DKA) before and after the start of isCGM. Data were collected from January 2015 to April 2020. Primary outcome was the rate of hypoglycemia requiring EMS involvement or hospital admission and DKA events. HbA1c was recorded at the start of isCGM and was compared with the last known HbA1c during the use of isCGM. The isCGM used in the study did not contain alarm functions. RESULTS: Altogether 220 hypoglycemic events were identified during the study period. Incidence rate of hypoglycemic events decreased after the start of isCGM (72 events, incidence rate 50 events/1000 person-years) compared with the time before the start (148 events, incidence rate 76 events/1000 person-years) (p = 0.043). The incidence rate of DKA decreased after the start of isCGM compared with time before isCGM use (4 and 15 events/1000 person-years, respectively; p = 0.002). The change in mean HbA1c was − 0.28% (− 3.1 mmol/mol) between baseline and the last HbA1c measurement (p < 0.001). CONCLUSIONS: In addition to lowering HbA1c in type 1 diabetes patients, isCGM is also effective in preventing acute diabetes-related complications such as hypoglycemia requiring EMS involvement or hospital admission and DKA. Springer Milan 2023-03-28 2023 /pmc/articles/PMC10198841/ /pubmed/36977968 http://dx.doi.org/10.1007/s00592-023-02079-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Mustonen, Jyrki
Rautiainen, Päivi
Lamidi, Marja-Leena
Lavikainen, Piia
Martikainen, Janne
Laatikainen, Tiina
The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title_full The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title_fullStr The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title_full_unstemmed The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title_short The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
title_sort use of iscgm leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198841/
https://www.ncbi.nlm.nih.gov/pubmed/36977968
http://dx.doi.org/10.1007/s00592-023-02079-y
work_keys_str_mv AT mustonenjyrki theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT rautiainenpaivi theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT lamidimarjaleena theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT lavikainenpiia theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT martikainenjanne theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT laatikainentiina theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT mustonenjyrki useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT rautiainenpaivi useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT lamidimarjaleena useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT lavikainenpiia useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT martikainenjanne useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients
AT laatikainentiina useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients